Graphite Bio, Inc. (GRPH) Social Stream
GRAPHITE BIO INC (GRPH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GRPH.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 4 | $35 | $34 | $34.666 | $2.43 | 1326.58% |
| 2022-01-28 | 4 | $35 | $30 | $33 | $2.43 | 1258.02% |
| 2022-01-31 | 4 | $34 | $19 | $27.666 | $2.43 | 1038.52% |
| 2022-02-18 | 5 | $34 | $11 | $23.5 | $2.43 | 867.08% |
| 2022-03-21 | 5 | $30 | $8 | $16.75 | $2.43 | 589.3% |
| 2022-04-13 | 5 | $24 | $8 | $15.25 | $2.43 | 527.57% |
| 2022-04-14 | 6 | $24 | $8 | $15.8 | $2.43 | 550.21% |
| 2022-05-16 | 6 | $18 | $8 | $13 | $2.43 | 434.98% |
| 2022-06-17 | 7 | $18 | $8 | $12.833 | $2.43 | 428.11% |
| 2022-07-15 | 5 | $18 | $6 | $12.5 | $2.43 | 414.4% |
| 2022-08-12 | 6 | $18 | $6 | $12.5 | $2.43 | 414.4% |
| 2022-08-13 | 7 | $18 | $6 | $12.5 | $2.43 | 414.4% |
| 2022-10-12 | 8 | $18 | $6 | $12.428 | $2.43 | 411.44% |
| 2022-10-24 | 8 | $18 | $6 | $11.571 | $2.43 | 376.17% |
| 2022-11-10 | 8 | $18 | $6 | $11.714 | $2.43 | 382.06% |
| 2022-11-13 | 8 | $18 | $6 | $11.428 | $2.43 | 370.29% |
| 2022-12-23 | 8 | $18 | $6 | $11.142 | $2.43 | 358.52% |
| 2023-01-06 | 8 | $18 | $2 | $8.142 | $2.43 | 235.06% |
| 2023-01-17 | 8 | $18 | $2 | $7.428 | $2.43 | 205.68% |
| 2023-01-23 | 8 | $18 | $2 | $6.857 | $2.43 | 182.18% |
| 2023-01-26 | 8 | $18 | $2 | $6.857 | $2.43 | 182.18% |
| 2023-02-08 | 8 | $18 | $2 | $6.428 | $2.43 | 164.53% |
| 2023-02-26 | 7 | $18 | $2 | $5.571 | $2.43 | 129.26% |
| 2023-03-21 | 8 | $18 | $2 | $5.714 | $2.43 | 135.14% |
| 2023-03-24 | 8 | $18 | $2 | $5.571 | $2.43 | 129.26% |
The Trend in the Analyst Price Target
Over the past 52 weeks, GRPH's average price target has gone down $9.68.
Over the past 49 weeks, GRPH's average upside potential has been 271.6%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-16 | 7 | 24 | 8 | 15.400 | 2.48 | 520.97% |
| 2022-07-15 | 5 | 18 | 6 | 12.500 | 3.31 | 277.64% |
| 2022-09-15 | 8 | 18 | 6 | 12.428 | 3.67 | 238.64% |
| 2022-09-17 | 8 | 18 | 6 | 12.428 | 3.44 | 261.28% |
| 2023-02-24 | 7 | 18 | 2 | 5.571 | 2.52 | 121.07% |
GRPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.13 | 0 | 0 | 7 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 52 weeks, GRPH's average broker recommendation rating worsened by 1.32.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- GRAPHITE BIO INC's variance in analysts' estimates is lower than -2407.32% of all US stocks.
- GRPH has a greater upside potential (average analyst target price relative to current price) than 2671.5% of all US stocks.
- GRAPHITE BIO INC's average analyst price target is higher than 479.57% of all US stocks.
- In the context of stocks in the small market cap category, GRAPHITE BIO INC's number of analysts covering the stock is higher than 2305.94% of them.
Stocks similar to GRAPHITE BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABOS, SOPH, and CADL.
View All Top Stocks by Price Target
Is GRPH a Buy, Hold or Sell? See the POWR Ratings now!